Progressive multifocal leukoencephalopathy in patients with sarcoidosis

Neurology

Volumn 82, Issue 15, 2014, Pages 1307-1313

  Jamilloux, Yvan ^a   Néel, Antoine ^b   Lecouffe Desprets, Marie ^b   Fèvre, Anne ^c   Kerever, Sebastien ^d   Guillon, Benoit ^b   Bouvry, Diane ^e   Varron, Loig ^a   Redares, Cécile ^f   Dominique, Stéphane ^g   Roux, Mareille ^h   Chapelon Abric, Catherine ⁱ   Valeyre, Dominique ^e   Ducray, François ^j   Bernard, Claire ^a   Broussolle, Christiane ^a   Hamidou, Mohamed ^b   Sève, Pascal ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e UNIVERSITÉ PARIS 13   (France)

^f Service de Médecine Interne et Gériatrie CH Belfort Montbéliard   (France)

^g HÔPITAL CHARLES NICOLLE   (France)

^h Service de Médecine Interne CH Oudot   (France)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j HÔPITAL NEUROLOGIQUE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; INFLIXIMAB; INTERLEUKIN 2; MEFLOQUINE; MIRTAZAPINE; ANTIVIRUS AGENT;

ADULT; ARTICLE; BASAL GANGLION; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DELAYED DIAGNOSIS; DRUG ERUPTION; DRUG TOLERANCE; FEMALE; FEVER; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RETROSPECTIVE STUDY; RISK FACTOR; SARCOIDOSIS; TREATMENT DURATION; TREATMENT OUTCOME; WHITE MATTER; BRAIN; DISEASE COURSE; PATHOLOGY;

ADRENAL CORTEX HORMONES; ADULT; ANTIVIRAL AGENTS; BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; RISK FACTORS; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 84902146845     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000318     Document Type: Article

References (41)

1. Matos A, Duque V, Beato S, da Silva JP, Major E, Meliço-Silvestre A. Characterization of JC human polyomavirus infection in a Portuguese population. J Med Virol 2010; 82: 494-504.
2. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010; 9: 425-437.
3. Koralnik IJ, Schellingerhout D, Frosch MP. Case records of the Massachusetts General Hospital: case 14-2004-a 66-year-old man with progressive neurologic deficits. N Engl J Med 2004; 350: 1882-1893. (Pubitemid 38917254)
4. Dhote R, Abad S, Valeyre D. The infectious complications of sarcoidosis [in French]. Presse Med 2009; 38: 317-323.
5. Christensen E, Fog M. A case of Schilder's disease in an adult with remarks to the etiology and pathogenesis. Acta Psychiatr Neurol Scand 1955; 30: 141-154.
6. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
7. Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 2013; 80: 1430-1438.
8. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis: diagnosis and management. QJM 1999; 92: 103-117. (Pubitemid 29097635)
9. Olindo S, Guillon B, Faighel M, Fève JR Progressive multifocal leukoencephalopathy and pulmonary sarcoidosis [in French]. Rev Neurol 2000; 156: 1013-1016.
10. Le Guilloux J, Roubiou C, Mallet J, et al. Atypical progressive multifocal leukoencephalopathy (PML) in a patient with pulmonary sarcoidosis [in French]. Rev Neurol 2010; 166: 341-345.
11. Marriott PJ, O'Brien MD, Mackenzie IC, Janota I. Progressive multifocal leucoencephalopathy: remission with cytarabine. J Neurol Neurosurg Psychiatr 1975; 38: 205-209.
12. Smith CR, Sima AA, Salit IE, Gentili F. Progressive multifocal leukoencephalopathy: failure of cytarabine therapy. Neurology 1982; 32: 200-203. (Pubitemid 12224006)
13. Rosenbloom MA, Uphoff DF. The association of progressive multifocal leukoencephalopathy and sarcoidosis. Chest 1983; 83: 572-575. (Pubitemid 13156513)
14. Iannarella G, Makdassi R, Schmit JL, et al. Association of progressive multifocal leukoencephalitis and sarcoidosis [in French]. Ann Med Interne 1992; 143: 71-74.
15. Steiger MJ, Tarnesby G, Gabe S, McLaughlin J, Schapira AH. Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 1993; 33: 407-411. (Pubitemid 23103977)
16. Heide W, Kömpf D, Reusche E, Bodemer M, Weber T. Failure of cytarabine/interferon therapy in progressive multifocal leukoencephalopathy. Ann Neurol 1995; 37: 412-413.
17. Mackowiak-Cordoliani MA, De Seze J, Stojkovic T, Ferriby D, Ingrand D, Vermersch P. Sarcoidosis and progressive multifocal leukoencephalopathy [in French]. Rev Neurol 2001; 157: 547-550. (Pubitemid 32565268)
18. Völker HU, Kraft K, Arnold E, Steinhoff S, Kolios G, Sommer S. Progressive multifocal leukoencephalopathy developing in advanced pulmonal sarcoidosis. Clin Neurol Neurosurg 2007; 109: 624-630. (Pubitemid 47016760)
19. Owczarczyk K, Hilker R, Brunn A, Hallek M, Rubbert A. Progressive multifocal leucoencephalopathy in a patient with sarcoidosis: successful treatment with cidofovir and mirtazapine. Rheumatology 2007; 46: 888-890. (Pubitemid 47061730)
20. De Raedt S, Lacor P, Michotte A, Flamez A, Ebinger G. Progressive multifocal leukoencephalopathy as first manifestation of sarcoidosis. Clin Neurol Neurosurg 2008; 110: 186-189.
21. Granot R, Lawrence R, Barnett M, et al. What lies beneath the tent? JC-virus cerebellar granule cell neuronopathy complicating sarcoidosis. J Clin Neurosci 2009; 16: 1091-1092.
22. Neeb L, Diekmann S, Blechschmidt C, et al. Infratentorial progressive multifocal leukoencephalopathy in a patient with pulmonary sarcoidosis. J Neurol 2009; 256: 1936-1938.
23. Yagi T, Hattori H, Ohira M, et al. Progressive multifocal leukoencephalopathy developed in incomplete Heerfordt syndrome, a rare manifestation of sarcoidosis, without steroid therapy responding to cidofovir. Clin Neurol Neurosurg 2010; 112: 153-156.
24. Goldbecker A, Tountopoulou A, Wurster U, et al. Spontaneous recovery from progressive multifocal leukoencephalopathy in a patient with non-active sarcoidosis. Int J Infect Dis 2010; 14(suppl 3): e313-e316.
25. Gofton TE, Al-Khotani A, O'Farrell B, Ang LC, McLachlan RS. Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatr 2011; 82: 452-455.
26. Park JH, Ryoo S, Noh HJ, et al. Dual therapy with cidofovir and mirtazapine for progressive multifocal leukoencephalopathy in a sarcoidosis patient. Case Rep Neurol 2011; 3: 258-262.
27. Hohlfeld SK, Günthard HF, Zeitz J, Locher P, Bachli E. Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis. BMJ Case Rep 2012; 2012.
28. Keith J, Bilbao J, Baskind R. JC virus granular neuronopathy and rhombencephalic progressive multifocal leukoencephalopathy: case report and review of the literature. Neuropathology 2012; 32: 280-284.
29. Pallin M, O'Sullivan C, Dodd JD, et al. A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis. QJM 2012; 105: 1011-1016.
30. Davis MJ, Khan A, Royal W III. Progressive multifocal leukoencephalopathy as the first manifestation of occult sarcoidosis: case report and review of the literature. Neurologist 2013; 19: 26-29.
31. Aksamit AJ. Review of progressive multifocal leukoencephalopathy and natalizumab. Neurologist 2006; 12: 293-298. (Pubitemid 44813665)
32. Delgado-Alvarado M, Sedano MJ, González-Quintanilla V, de Lucas EM, Polo JM, Berciano J. Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia. J Neurol Sci 2013; 327: 75-79.
33. Horger M, Beschorner R, Beck R, et al. Common and uncommon imaging findings in progressive multifocal leukoencephalopathy (PML) with differential diagnostic considerations. Clin Neurol Neurosurg 2012; 114: 1123-1130.
34. Manenti G, Altobelli S, Nezzo M, et al. Early magnetic resonance detection of natalizumab-related progressive multifocal leukoencephalopathy in a patient with multiple sclerosis. Case Rep Radiol 2013; 2013: 415873.
35. Bernard C, Maucort-Boulch D, Varron L, et al. Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases. QJM 2013; 106: 523-539.
36. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998; 4: 59-68. (Pubitemid 28081579)
37. Boren EJ, Cheema GS, Naguwa SM, Ansari AA, Gershwin ME. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun 2008; 30: 90-98.
38. De Luca A, Ammassari A, Pezzotti P, et al. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS 2008; 22: 1759-1767.
39. Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004; 306: 1380-1383. (Pubitemid 39532516)
40. Vermersch P, Kappos L, Gold R, et al. Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology 2011; 76: 1697-1704.
41. Marzocchetti A, Tompkins T, Clifford DB, et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 2009; 73: 1551-1558.